Objectives: The objective was to define the characteristics of a real-world patient population
treated with transcatheter aortic valve implantation (TAVI), regardless of technology or …

Abstract Objectives: The UK Transcatheter Aortic Valve Implantation Registry reported 30-
day and 1-year mortality rates of 7.1% and 21.4%, respectively, for patients who underwent …

Transcatheter aortic valve implantation (TAVI) with the Cribier-Edwards prosthesis may
provide an alternative to conventional aortic valve replacement in high-risk patients with …

Transcatheter aortic valve implantation (TAVI) is already an accepted option to treat elderly
patients with severe symptomatic aortic stenosis who are inoperable or at high surgical risk …

Background Transcatheter aortic valve implantation/replacement (TAVI/TAVR) is becoming
more frequently used to treat aortic stenosis (AS), with increasing push for the procedure in …

Objectives: This study sought to evaluate the long-term outcomes after transcatheter aortic
valve implantation (TAVI) in the Multicenter Canadian Experience study, with special focus …

Surgical aortic valve replacement (SAVR) is currently the standard of care to treat patients
with severe symptomatic aortic stenosis (AS) and is generally accepted to alleviate …

Transcatheter aortic valve implantation (TAVI) or replacement has rapidly changed the
treatment of patients with severe symptomatic aortic stenosis. It is now the standard of care …

Background Transcatheter aortic valve implantation (TAVI) has been adopted worldwide as
the standard treatment for severe aortic stenosis in symptomatic patients at prohibitive or …

The aim of this study was to identify predictors of 30-day and midterm mortality after
transcatheter aortic valve implantation (TAVI) by means of a systemic review. TAVI was …